{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:57:59Z","timestamp":1792180679847,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010847","name":"Jiangxi Province Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnesp.2025.07.028","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T23:23:18Z","timestamp":1752880998000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Skeletal muscle gauge: A superior predictor of neoadjuvant chemoimmunotherapy efficacy in locally advanced gastric cancer"],"prefix":"10.1016","volume":"70","author":[{"given":"Zhi-Yong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Yang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Xun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-Bao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnesp.2025.07.028_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J Clin"},{"issue":"21","key":"10.1016\/j.clnesp.2025.07.028_bib2","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clnesp.2025.07.028_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"21","key":"10.1016\/j.clnesp.2025.07.028_bib4","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clnesp.2025.07.028_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"key":"10.1016\/j.clnesp.2025.07.028_bib6","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","article-title":"Insulin resistance and body composition in cancer patients","volume":"29","author":"Dev","year":"2018","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clnesp.2025.07.028_bib8","first-page":"17","article-title":"Molecular mechanisms of Cachexia","volume":"13","author":"Neshan","year":"2024","journal-title":"Review"},{"key":"10.1016\/j.clnesp.2025.07.028_bib9","series-title":"Minireview Role of myokines and osteokines in cancer cachexia Cancer cachexia","first-page":"1","author":"Pin","year":"2021"},{"issue":"1","key":"10.1016\/j.clnesp.2025.07.028_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcsm.12484","article-title":"Prognostic role of body composition parameters in gastric\/gastroesophageal junction cancer patients from the EXPAND trial","volume":"11","author":"Hacker","year":"2020","journal-title":"J Cachexia, Sarcopenia and Muscle"},{"issue":"1","key":"10.1016\/j.clnesp.2025.07.028_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcsm.12234","article-title":"Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer","volume":"9","author":"Choi","year":"2018","journal-title":"J Cachexia, Sarcopenia and Muscle"},{"key":"10.1016\/j.clnesp.2025.07.028_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2018.09.026","article-title":"Financial impact of sarcopenia or low muscle mass - a short review","volume":"38","author":"Norman","year":"2019","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnesp.2025.07.028_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4174\/astr.2024.106.6.305","article-title":"Sarcopenia diagnosis in patients with colorectal cancer: a review of computed tomography-based assessments and emerging ways to enhance practicality","volume":"106","author":"Cho","year":"2024","journal-title":"Ann Surg Treat Res"},{"issue":"2","key":"10.1016\/j.clnesp.2025.07.028_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14740\/gr1707","article-title":"Clinical overview of sarcopenia, frailty, and malnutrition in patients with liver cirrhosis","volume":"17","author":"Kusnik","year":"2024","journal-title":"Gastroenterol Res"},{"issue":"8","key":"10.1016\/j.clnesp.2025.07.028_bib16","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1016\/j.clnu.2021.06.021","article-title":"Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study","volume":"40","author":"Lin","year":"2021","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.surg.2019.07.033","article-title":"Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy","volume":"166","author":"Ishida","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.clnesp.2025.07.028_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1061044","article-title":"Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2025.07.028_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1440-1681.2007.04752.x","article-title":"Age-related changes in the structure and function of skeletal muscles","volume":"34","author":"Faulkner","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"10.1016\/j.clnesp.2025.07.028_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol: Official J Am Society of Clin Oncol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12603-010-0081-2","article-title":"Skeletal muscle fat infiltration: impact of age, inactivity, and exercise","volume":"14","author":"Marcus","year":"2010","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jcsm.12771","article-title":"Sarcopenia and major complications in patients undergoing oncologic colon surgery","volume":"12","author":"Schneider","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.clnesp.2025.07.028_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jcsm.12848","article-title":"Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels","volume":"13","author":"Marquardt","year":"2022","journal-title":"J Cachexia, Sarcopenia and Muscle"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib24","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1245\/s10434-024-14913-w","article-title":"Predictive value of a new muscle parameter in patients with resectable gastric cancer: a pooled analysis of three prospective trials","volume":"31","author":"Zhong","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol = Physiologie appliquee, nutrition et metabolisme"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jcsm.12573","article-title":"Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients","volume":"11","author":"Cespedes Feliciano","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/annonc\/mdp464","article-title":"Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)","volume":"21","author":"Koizumi","year":"2010","journal-title":"Ann Oncol : Off J Eur Soci Med Oncol"},{"key":"10.1016\/j.clnesp.2025.07.028_bib28","series-title":"Japanese gastric cancer treatment guidelines 2018","author":"Japanese Gastric Cancer","year":"2020"},{"key":"10.1016\/j.clnesp.2025.07.028_bib29","series-title":"Japanese gastric cancer treatment guidelines 2018","first-page":"1","author":"Association","year":"2020"},{"key":"10.1016\/j.clnesp.2025.07.028_bib30","series-title":"AJCC cancer staging manual","author":"Edge","year":"2017"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.clnesp.2025.07.028_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/j.clnesp.2025.07.028_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"2","key":"10.1016\/j.clnesp.2025.07.028_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ctrv.2013.06.007","article-title":"Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps and future research directions","volume":"40","author":"Buffart","year":"2014","journal-title":"Cancer Treatment Rev"},{"issue":"7","key":"10.1016\/j.clnesp.2025.07.028_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1365-2168.2002.02135.x","article-title":"Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers","volume":"89","author":"Bachmann","year":"2002","journal-title":"Br J Surgery"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","article-title":"Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer","volume":"26","author":"Tamandl","year":"2016","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.surg.2015.02.002","article-title":"Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer","volume":"157","author":"Okumura","year":"2015","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.clnesp.2025.07.028_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1017\/S0007114512001067","article-title":"Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia","volume":"109","author":"Di Sebastiano","year":"2013","journal-title":"British J Nutr"},{"key":"10.1016\/j.clnesp.2025.07.028_bib39","article-title":"Age-associated loss of power and strength in the upper extremities in women and men","volume":"B267","author":"Jeffrey","year":"1997","journal-title":"J Gerontol A Biol Med"},{"issue":"7","key":"10.1016\/j.clnesp.2025.07.028_bib40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF02982704","article-title":"Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives","volume":"12","author":"Rolland","year":"2008","journal-title":"J Nutri Health Aging"},{"issue":"3","key":"10.1016\/j.clnesp.2025.07.028_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tbj.12952","article-title":"Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population","volume":"24","author":"Weinberg","year":"2018","journal-title":"Breast J"},{"key":"10.1016\/j.clnesp.2025.07.028_bib42","first-page":"1","volume":"389","author":"Lancet","year":"2017"},{"issue":"4","key":"10.1016\/j.clnesp.2025.07.028_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194697","article-title":"Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study","volume":"13","author":"Abramowitz","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.clnesp.2025.07.028_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.clnesp.2025.07.028_bib45","first-page":"1","volume":"21","author":"Warner","year":"2019"},{"issue":"5","key":"10.1016\/j.clnesp.2025.07.028_bib46","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00432-020-03146-5","article-title":"Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors","volume":"146","author":"Takada","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.07.028_bib47","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41598-020-58498-2","article-title":"Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: a multicenter real-life study","volume":"10","author":"Cortellini","year":"2020","journal-title":"Scientific Rep"},{"key":"10.1016\/j.clnesp.2025.07.028_bib48","series-title":"T-Cell exhaustion","author":"Mehlhorn","year":"2016"},{"issue":"7693","key":"10.1016\/j.clnesp.2025.07.028_bib49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u00ce\u00b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.clnesp.2025.07.028_bib50","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-18-0118","article-title":"Combined blockade of IL6 and PD-1\/PD-L1 Signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.clnesp.2025.07.028_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7110","article-title":"Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor","volume":"13","author":"Deng","year":"2024","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.clnesp.2025.07.028_bib52","first-page":"192","article-title":"Clinical impact of skeletal muscle mass and nutritional status in patients with recurrent or advanced gastric cancer treated with nivolumab","volume":"103","author":"Hu","year":"2025","journal-title":"Oncology"},{"issue":"12","key":"10.1016\/j.clnesp.2025.07.028_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7328","article-title":"CT-determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer","volume":"13","author":"Feng","year":"2024","journal-title":"Cancer Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725017796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725017796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:37:18Z","timestamp":1764405438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725017796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S2405457725017796"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.07.028","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal muscle gauge: A superior predictor of neoadjuvant chemoimmunotherapy efficacy in locally advanced gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}